Endocrinology and Clinical Metabolic Research
A section of Metabolites (ISSN 2218-1989).
Section Information
Metabolites and metabolism have long been key parts of endocrinology and clinical metabolic research. This section of Metabolites now provides a venue to focus on these areas of investigation. In addition to those areas of traditional interest, such as precision medicine, biomarker discovery and inborn errors of metabolism, other clinically relevant areas will also be given full consideration.
These include, but are not limited to, original research and review articles on:
- metabolism in endocrine disorders
- cardio-metabolic risk
- fatty liver disease (NAFLD-NASH/MAFLD); cryptogenic and NAFLD-cirrhosis; NAFLD-HCC
- chronic kidney disease; fatty pancreas and gut microbiota
- adiposopathy and pathophysiology of adipose tissue
- immunity and metabolism
- metabolic derangements in infectious diseases
- sex medicine as applied to normal and deranged metabolism
- lifestyle and metabolism; chronometabolism; intermittent fasting
- biochemical and molecular characterization of pathophenotypes in internal medicine
In all these areas and many others, multidisciplinary and molecular approaches will represent added value. We hope our readers will appreciate the section “Endocrinology and Clinical Metabolic Research” and look forward to receiving high-quality scientific submissions from all over the world, while committing ourselves to the rapid and accurate processing of manuscripts.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Tumoral Microenvironment and Metabolic Reprogramming in Cancer (Deadline: 15 July 2026)
- Exploring Metabolomic Signatures and the Metabolic Impact of Thyroid Dysfunction (Deadline: 17 July 2026)
- Thyroid Dysfunction and Metabolic Disorders (Deadline: 20 July 2026)
- Metabolic Signatures of Pediatric Endocrine and Metabolic Disorders (Deadline: 20 July 2026)
- Physical and Nutritional Lifestyle Contributions to Metabolic Health and Well-Being (Deadline: 20 July 2026)
- Metabolomics and MASLD: Pathways, Biomarkers, and Clinical Insights (Deadline: 31 July 2026)
- Advancing Metabolic/Microbial Biomarker Applications in Disease Prevention, Diagnosis and Public Health (Deadline: 31 July 2026)
- Metabolomics Biomarker Discovery in Respiratory, Cardiovascular and Metabolic Disorders (Deadline: 15 August 2026)
- Emerging Inflammatory and Metabolic Biomarkers in Hayfever (Deadline: 15 August 2026)
- Current Research in Metabolic Syndrome and Cardiometabolic Disorders (Deadline: 15 August 2026)
- Role of Lipid Metabolism in Cardiovascular Health (Deadline: 15 August 2026)
- Connections Between Nutrition, Epidemiology, and Metabolism (Deadline: 15 August 2026)
- Metabolite Profiles in Inflammatory Diseases (Deadline: 15 August 2026)
- Metabolomic Signatures in Cancer (Deadline: 20 August 2026)
- Mechanisms and Prevention in Steatotic Liver Disease (Deadline: 20 August 2026)
- Biological Markers of Chronic Inflammatory Diseases (Deadline: 20 August 2026)
- Advances in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (Deadline: 21 August 2026)
- Metabolic Disorders and Inflammatory Bowel Diseases (Deadline: 25 August 2026)
- Advances in Cancer Metabolism (Deadline: 5 September 2026)
- Obesity and Metabolic Dysfunction: Disease Development and Breaking the Cycle (Deadline: 15 September 2026)
- Advances in Metabolic Dysfunction-Associated Steatotic Liver Disease (Deadline: 15 September 2026)
- Metabolomics in Infectious Diseases (Deadline: 15 September 2026)
- Metabolic Dysfunction in Diabetic Neuropathy (Deadline: 15 September 2026)
- Changes in Body Composition (Bone, Muscle, Adipose Tissue) with Age and Accompanying Biomarkers for Each Tissue (Deadline: 15 September 2026)
- Metabolic Biomarkers in Cardiometabolic Disease: Early Detection, Risk Assessment, and Guiding Treatment (Deadline: 15 September 2026)
- The Influencing Factors of Metabolic Changes in Polycystic Ovary Syndrome (Deadline: 20 September 2026)
- Redox Signaling and Metabolic Changes in Liver Diseases (Deadline: 20 September 2026)
- Obesity and Metabolic Health, 2nd Edition (Deadline: 25 September 2026)
- Management of Diabetes and Its Metabolic Complications (Deadline: 12 October 2026)
- Metabolic Responses to Exercise Training (Deadline: 15 October 2026)
- Microbiome in Diabetes Progression and Insulin Resistance (Deadline: 15 October 2026)
- Metabolomics and Lipidomics in MASLD and Related Liver Disorders (Deadline: 15 October 2026)
- Research on Metabolic Biomarkers in Different Diseases (Deadline: 30 October 2026)
- Metabolic Insights into Perioperative Cardiovascular Risk and Outcomes (Deadline: 31 October 2026)
- Metabolomics in Clinical Research: Advancing Precision Medicine Through the Analysis of Biological Samples (Deadline: 31 October 2026)
- Muscle Wasting in Metabolic Dysfunction: Mechanisms and Therapeutic Innovations (Deadline: 31 October 2026)
- The Aging Blueprint: Decoding Biomarkers of Bone and Muscle Health (Deadline: 31 October 2026)
- The Association Between Metabolic Dysfunction-Related Fatty Liver Disease and Cardiovascular Diseases (Deadline: 20 November 2026)
- Metabolic Alterations in Chronic Viral Infections (Deadline: 20 November 2026)
- Metabolomics and Biomarker Discovery in Critical Care Therapeutics (Deadline: 20 November 2026)
- Early Metabolic Dysfunction in Children and Adolescents: The Role of Oxidative Stress and Micronutrients (Deadline: 20 November 2026)
- Bile Acid Transport and Metabolic Disorders (Deadline: 30 November 2026)
- Advances in Metabolomics for Precision Medicine: From Biomarker Discovery to Clinical Applications: 2nd Edition (Deadline: 30 November 2026)
- The Multifaceted Roles of Biomarkers in Metabolic Disorders: From Diagnosis and Monitoring to Prediction, Management, and Treatment, 2nd Edition (Deadline: 5 December 2026)
- Effects of Nutrition Intake and Lifestyle Intervention on Human Metabolic Health (Deadline: 15 December 2026)
- Research on Biomarkers for Cardiometabolic Risk in Metabolic Syndrome—2nd Edition (Deadline: 15 December 2026)
- Metabolic Signature of Type 2 Diabetes, Insulin Resistance, and Obesity Triad (Deadline: 15 December 2026)
- Metabolic Dysfunction-Associated Steatotic Liver Disease: From Pathophysiology to Prevention Strategies (Deadline: 20 December 2026)
- Fat and Glucose Metabolism: Mechanisms and Regulation (Deadline: 31 December 2026)
- Biomarkers and Metabolites in Clinical Practice and Research (Deadline: 31 December 2026)
- Metabolic Factors in Neurodegenerative Diseases: Mechanisms, Biomarkers, and Therapy (Deadline: 31 December 2026)
- Metabolic Adaptations to Exercise: Mechanisms, Modulators, and Health Impacts (Deadline: 31 December 2026)
- Metabolic Regulation in Cancer Development and Progression (Deadline: 31 December 2026)
- Exploring Pathological Mechanisms in Obesity, Diabetes, and Metabolic Syndrome: 2nd Edition (Deadline: 31 December 2026)
- Nutrition, Metabolism and Clinical Management of Liver Diseases (Deadline: 15 January 2027)
- Beyond Metabolism: The Expanding Role of GLP-1 Receptor Agonists in Modern Medicine (Deadline: 31 January 2027)
- Effects of Exercise and Lifestyle on Cardiometabolic Health (Deadline: 25 February 2027)
- The Role of Lifestyle, Physical Activity, and Exercise on Cardiometabolic Health and Diseases (Deadline: 28 February 2027)
- Advances in Brain Energy Metabolism Research (Deadline: 20 March 2027)
- Circadian Regulation of Metabolic Health from Molecular Mechanisms to Human Physiology (Deadline: 31 March 2027)
- Inflammation and Oxidative Stress in the Metabolic Syndrome (Deadline: 10 April 2027)
- Metabolomics for Clinical Biomarkers Discovery (Deadline: 30 April 2027)
- Metabolic Reprogramming in Therapy-Resistant Cancer (Deadline: 20 July 2027)